Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Frazier Healthcare Partners has acquired Altruix, a behavioral health business in California. Altruix provides behavioral health services and technology-enabled care support, supporting treatment coordination and patient outcomes. Frazier Healthcare Partners acquisitions in healthcare M&A focus on expanding access to behavioral health programs through a private equity acquisition of Altruix. The other acquisition is announced and includes the appointment of Randy Hyun as CEO to lead operations and growth. Deal size was not disclosed, and the parties did not specify expected closing terms.
Source
Read full article on businesswire.comvia GN - behavioral mental health acquired · May 31, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026
Garner Health
May 29, 2026